Charles River Laboratories International (CRL) Retained Earnings (2009 - 2025)

Charles River Laboratories International's Retained Earnings history runs 17 years deep, the most recent figure standing at -$171.8 million for Q4 2025.

• In Q4 2025, Retained Earnings rose 45.87% year-over-year to -$171.8 million; the TTM figure through Dec 2025 stood at -$171.8 million (up 45.87% YoY), while the FY2025 annual figure was -$171.8 million, up 45.87% from the prior year.
• Retained Earnings for Q4 2025 stood at -$171.8 million, up from -$191.6 million in the prior quarter.
• The five-year high for Retained Earnings was $2.1 billion in Q3 2024, with the low at -$395.6 million in Q3 2022.
• The 5-year median for Retained Earnings is -$168.3 million (2021), against an average of $411.0 million.
• The sharpest annual moves came in 2022 and 2023: Retained Earnings sank 197.94% in 2022, then soared 978.07% in 2023.
• Charles River Laboratories International's Retained Earnings stood at -$164.7 million in 2021, then soared by 969.8% to $1.4 billion in 2022, then soared by 31.71% to $1.9 billion in 2023, then tumbled by 116.82% to -$317.3 million in 2024, then surged by 45.87% to -$171.8 million in 2025.
• Business Quant data shows CRL's Retained Earnings at -$171.8 million in Q4 2025, -$191.6 million in Q3 2025, and $1.9 billion in Q2 2025.